Moderna Inc (NASDAQ: MRN) shares are surging above the $70 level for the first time since late May following sell-side commentary on its coronavirus vaccine program. The Moderna Analyst: Jefferies analyst Michael Yee initiated coverage of Moderna with a Buy rating and $90 price target. The Moderna Thesis: There is good probability the vaccine will work…
3 min read IN THIS DAY and age it can be easy to drift in and out while watching a TV show or movie. Everybody's focus is fractured, we're all overstimulated, and attention has become a currency. And if we're being honest, there are some shows or movies where you can look a away for
You probably don’t need a survey to tell you parents are stressed out right now, but in case you do: A recent government report found that 48% of parents say that their stress is “completely overwhelming” on most days—more than double what other adults report. Why am I mentioning this? The new Dietary Guidelines for
13 min read I'M STOOD IN the immigration queue at Düsseldorf airport, here to attend the Ed Sheeran Mathematics tour, one of the last stops in what has been an epic four-year journey for the 34-year-old. Selling 8.8 million tickets across 188 dates, it has become the fourth-highest grossing tour of all time, behind only